A growing number of clinicians rely on AdaptDx to detect age-related macular degeneration in their adult patients. Our customers tell the story of how they’re fighting against blindness caused by AMD.
Thanks to the comprehensive AMD Excellence training program from MacuLogix, each staff member - from the front desk and optical to technicians and billing - understands the important role they play in AMD care.
The impact of the AdaptDx on my patient care and practice revenue has been phenomenal!
Now that we are using the AdaptDx to diagnose AMD earlier and actively manage disease progression, I’m confident we will improve outcomes in both eyes by catching CNV before significant vision loss occurs.
The AdaptDx is simple for the patient and takes little staff training to become proficient at administering. Analyzing the data by the doctor only takes seconds and is very simple to interpret. This allows more time to discuss with the patient the results and the plan of action when needed.
The test is a great benchmark that I use to determine depth of the disease and how soon the patient needs to return for another visit.
AdaptDx more than paid for itself within the first few months.
Equipment companies usually ship you a big box and you never hear from them again. That was not the case with MacuLogix and their AdaptDx. They spent 2 days with us and did a fantastic job training our whole office!
I strongly believe that if we can catch AMD at a very early stage and be really proactive with recommending supplements, blue light filters, sunglasses, telling them to watch their BMI, their cholesterol levels, that we can stop or slow this down and maintain their vision the rest of their life.
Our doctors decided that we should be doing an AMD screening for our patients over the age of 65 no matter what. Photos and looking at the macula is just not enough. If you look at the statistics, it makes more sense to do an AdaptDx test on this population than it does to take a tonometry reading to screen for glaucoma!! We decided we wanted to be more proactive and take better care of our patients. Using the AdaptDx to find subclinical AMD enables us to do just that.
Just like the OCT, I don't know how I practiced without the AdaptDx. From being able to diagnose AMD before we see any clinical signs and being able to monitor at the correct follow-up time for my patients that have AMD is wonderful. I felt like it was just a shot in the dark as to when I should have early AMD patients return, but now knowing their rod intercept, I can confidently say exactly when their follow-ups should be.